Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million peopleJulia Hippisley-Cox, Duncan Young, Carol Coupland, Keith M Channon, Pui San Tan, David A Harrison, Kathryn Rowan, Paul Aveyard, Ian D Pavord, Peter J Watkinson
31 July 2020
Observational data during the COVID-19 pandemic: opportunity with uncertaintySam Straw, Klaus K Witte
5 August 2020
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19Giulio G. Stefanini, Mauro Chiarito, Giuseppe Ferrante, Francesco Cannata, Elena Azzolini, Giacomo Viggiani, Andrea De Marco, Martina Briani, Monica Bocciolone, Renato Bragato, Elena Corrada, Gabriele L Gasparini, Manuel Marconi, Lorenzo Monti, Paolo A PagnottaSee the full list of authors
14 August 2020
Heartbeat: interaction of renin–angiotensin–aldosterone blocking drugs with COVID-19 disease susceptibility and severityCatherine M Otto
14 September 2020
Adult congenital heart disease and the COVID-19 pandemicRobert M Radke, Tim Frenzel, Helmut Baumgartner, Gerhard-Paul Diller
10 June 2020
Flattening the curve in COVID-19 using personalised protective equipment: lessons from air pollutionSanjay Rajagopalan, Sui Huang, Robert D Brook
11 May 2020
Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19Matteo Pagnesi, Luca Baldetti, Alessandro Beneduce, Francesco Calvo, Mario Gramegna, Vittorio Pazzanese, Giacomo Ingallina, Antonio Napolano, Renato Finazzi, Annalisa Ruggeri, Silvia Ajello, Giulio Melisurgo, Paolo Guido Camici, Paolo Scarpellini, Moreno TresoldiSee the full list of authors
16 July 2020
Challenges in the management of older patients with acute coronary syndromes in the COVID-19 pandemicBen Rowland, Vijay Kunadian
22 May 2020
Cardiovascular disease and COVID-19: implications for prevention, surveillance and treatmentNeal A Chatterjee, Richard K Cheng
25 May 2020
Getting to the heart of the matter of COVID-19David E Newby, Kazem Rahimi
27 May 2020